Biotech | April 03, 2026
Nearly 40 industry groups unite to push for EU Biotech Act II
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Hologic has been at the forefront of cervical cancer screening for decades
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
Subscribe To Our Newsletter & Stay Updated
